BALANCING PATENT AND PUBLIC HEALTH - A LEGAL APPRAISAL OF RELEVANCE OF TRIPS AND DOHA DECLARATION IN INDIAN PHARMACEUTICAL INDUSTRY

Abstract

This paper examines the impact of the TRIPS Agreement and the Doha Declaration on pharmaceutical patents in India, analyzing legal frameworks, compulsory licensing, and innovation implications. It highlights how these mechanisms influence access to affordable medicines, ensuring public health while fostering innovation within the pharmaceutical sector. Through statistical insights and case studies, including significant legal battles, the research underscores the balance between patent protection and the need for accessible healthcare in developing countries. Ultimately, it emphasizes the importance of sustainable patent policies in enhancing both public health and global pharmaceutical competitiveness.